Short-term use of unopposed estrogen: a balance of inferred risks and benefits.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women.Menopause (New York, N.Y.) · 2015
   Article
2. Hormone therapy use in women veterans accessing veterans health administration care: a national cross-sectional study.Journal of general internal medicine · 2015
   Article
3. Premature menopause or early menopause and risk of ischemic stroke.Menopause (New York, N.Y.) · 2012
   Review
4. Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women.Carcinogenesis · 2011
   Article
5. Hot flashes: a review of pathophysiology and treatment modalities.The oncologist · 2011
   Review

Corrections and comments

• Comment on
  Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.2011
• Erratum issued

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as